Latest Bayer Inc. Stories
Treatment of Visual Impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) and Diabetic Macular Edema (DME) are the Second and Third Indications for Eylea(®) in Canada
-- Bayer becomes the OTC leader in North and Latin America and achieves top global positions in key OTC categories -- Erica Mann heads Bayer's new consumer care business globally
One in three millennial women pill users forget to take their pill at least once per cycle TORONTO, Sept.
-- Nexavar is the only approved treatment for patients with RAI-refractory differentiated thyroid cancer -- Nexavar significantly extended progression-free survival
Inspirational video is launched on World Hemophilia Day to tell the story of one Canadian's triumph over adversity TORONTO, April 17, 2014 /CNW/ - Attitude makes you a hero;
-- Bayer's Adempas (riociguat tablets) approved for the treatment of pulmonary arterial hypertension (PAH)(1), which affects up to 2000 Canadians(2) -- Adempas provides
Survey found that worrying about a birth control fail negatively impacts quality of sex TORONTO, Feb.
- An imitative word; an onomatopoetic word.